Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: A retrospective study

Hepatology

Volumn 58, Issue 5, 2013, Pages 1580-1586

  Mohan, Parvathi ^a   Barton, Bruce A ^b   Narkewicz, Michael R ^c   Molleston, Jean P ^d   Gonzalez Peralta, Regino P ^e   Rosenthal, Philip ^f   Murray, Karen F ^g   Haber, Barbara ^h   Schwarz, Kathleen B ⁱ   Goodman, Zachary D ^j  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SEATTLE CHILDREN S HOSPITAL   (United States)

^h MERCK RESEARCH LABORATORIES   (United States)

ⁱ Johns Hopkins i'Nneisih School of Medicine   (United States)

^j INOVA FAIRFAX HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SCHOOL CHILD; TRANSFUSION;

ADOLESCENT; ALANINE TRANSAMINASE; BIOPSY; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INFANT; LIVER; LIVER CIRRHOSIS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84887025025     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26519     Document Type: Article

References (31)

1. Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999:341:866-870.
2. Casiraghi MA, Paschale MD, Romano L, Biffi R, Assi A, Binelli G, et al. Long term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004;39:90-96.
3. Hoshiyama A, Kimura A, Fujisawa T, Kage M, Kato H. Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 2000;105:62-65.
4. Guido M, Rugge M, Jara P, Hierro L, Giacchino R, Larrauri J, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998;115:1525-1529.
5. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-1423.
6. Mohan P, Colvin C, Glymph C, Chandra RR, Kleiner DE, Patel KM, et al. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007;150:168-174.
7. González-Peralta RP, Langham MR Jr, Andres JM, Mohan P, Colombani PM, Alford MK, et al. Hepatocellular carcinoma in two young adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2009;48:630-635.
8. Jara P, Hierro L, Vega A, Diaz C, Camarena C, Frauca E, et al. Efficacy and safety of peginterferon-α2b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J 2008;27:142-148.
9. Wirth S, Ribes-Koninckx C, Calzado MA, Bortollotti F, Zancan L, Jara P, et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010;52:501-507.
10. Sokal EM, Bourgois A, Stephenne X, Silveira T, Porta G, Gardovska D, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents. J Hepatol 2010;52:827-831.
11. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, et al. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Peds-C Clinical Research Network. Gastroenterology 2011;140:450-458.
12. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in Hepatitis C. Hepatology 2002;36:S47-S56.
13. Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003;124:97-104.
14. Hoefs JC, Shiffman ML, Goodman ZD, Kleiner DE, Dienstag JL, Stoddard AM, and the HALT-C Trial group. Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C trial. Gastroenterology 2011;141:900-908.
15. Albloushi SS, Murray FE, Callagy G, Courtney MG, O'Keane JC, Kay E, et al. Changes in liver histopathology in women infected with hepatitis C through contaminated anti-D immunoglobulin injections in Ireland. Eur J Gastroenterol Hepatol 1998;10:69-73.
16. Castera L, Hezode C, Roudot-Thoraval F, Bastie A, Zafrani E-S, Pawlotsky J-M, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003;52:288-292.
17. Ryder SD, Trend Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004;53:451-455.
18. Collier JD, Woodall T, Wight DGD, Shore S, Gimson AE, Alexander GJM. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection. J Viral Hepat 2005;12:74-80.
19. Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, et al. Progression of liver fibrosis among injection drug users with chronic hepatitis C Hepatology 2006;43:788-795.
20. Fujiwara A, Sakaguchi K, Fujioka S, Iwasaki Y, Senoh T, Nishimura M, et al. Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels. J Gastroenterol 2008;43:484-491.
21. Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, Rosenthal P, et al. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr 2012;54:838-855.
22. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C trial. Hepatology 2008;47:836-843.
23. Murray KF, Rodrigue JR, González-Peralta RP, Shepherd J, Barton BA, Robuck PR, et al. for the PEDS-C Clinical Research Network. Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection. Clin Trials 2007;4:661-673.
24. Guido M, Bortolloti F, Leandro G, Jara P, Hierro L, Larrauri J, et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003;98:660-663.
25. Bortolloti F, Verucchi G, Camma C, Cabibbo G, Zancan L, Indolfi G, et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008;134:1900-1907.
26. Birnbaum AH, Schneider BL, Moy L. Hepatitis C in children. N Engl J Med 2000;342:290-292.
27. Bedossa P, Dargére D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.
28. Skripenova S, Trainer TD, Krawitt EL, Blaszyk H. Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J Clin Pathol 2007;60:321-324.
29. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histologic evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239-244.
30. Guido M, Bortolloti F. Chronic viral hepatitis in children: any role for the pathologist? Gut 2008;57:873-877.
31. Jara P, Hierro L. Treatment of hepatitis C in children. Expert Rev Gastroenterol Hepatol 2010;4:51-61.